Massachusetts Medical Society: Prescriber Education on Opioids Surpasses 20,000 courses

Prescriber Education on Opioids Surpasses 20,000 courses

Contact: Richard Gulla
781-434-7101
rgulla@mms.org

Waltham, Mass. -- The Massachusetts Medical Society today provided an update on its prescriber education effort to address the opioid epidemic in the Commonwealth and said that more than 7,000 prescribers had taken more than 20,000 of its continuing medical education courses in opioids and pain management.

The Society began offering its education courses in opioids and pain management free to all prescribers following the release of its Opioid Therapy and Physician Communication Guidelines. The guidelines were developed to provide direction to physicians in their practices and to offer evidence of best practices in prescribing and were subsequently adopted by the Massachusetts Board of Registration in Medicine, which incorporated them into its comprehensive advisory to physicians on prescribing issues and practices. 

In May of 2015, the Society began offering its medical education courses in opioids and pain management free to all prescribers as a way to increase awareness of the epidemic among health care professionals and to remove barriers to prescriber education.

The Society’s prescriber education offerings include 18 courses and modules, with such titles as New Opioid Prescribing Guidelines in Practice, Managing Pain Without Overusing Opioids, Safe Opioid Prescribing for Chronic Pain, The Opioid Epidemic: Policy and Public Health, and Alternatives to Opioids

Massachusetts Medical Society President James S. Gessner, M.D., reported that as of October 7, a total of 20,249 courses have been taken by 7,084 prescribers since the courses were first offered free on May 26 of last year. 

“Prescriber education remains one of the critical steps in alleviating the opioid crisis,” Dr. Gessner said, “and we are pleased that our organization is making this contribution and are encouraged that it is having an impact.”
 
Dr. Gessner cited three studies released earlier this year that show opioid prescribing rates have declined.  The studies were done by athenahealth, the Cambridge-based Workers’ Compensation Research Institute, and the Massachusetts Department of Public Health

Despite the progress in prescribing, Dr. Gessner said that treatment for opioid use disorder is another critical step to change the direction of the epidemic. To assist in this area, Dr. Gessner said the Society is conducting a Medication Assisted Treatment Summit on October 31.

The event will convene leaders in medicine, public health, policy, industry, and the community to discuss strategies to expand availability and access to evidence-based treatments for opioid addiction, and to identify collaborative strategies to increase positive treatment outcomes.

The Massachusetts Medical Society, with more than 25,000 physicians and student members, is dedicated to educating and advocating for the patients and physicians of Massachusetts. The Society, under the auspices of NEJM Group, publishes the New England Journal of Medicine, a leading global medical journal and web site, and Journal Watch alerts and newsletters covering 13 specialties. The Society is also a leader in continuing medical education providing accredited and certified activities across the globe for physicians and other health care professionals.  Founded in 1781, MMS is the oldest continuously operating medical society in the country. For more information please visit www.massmed.org, www.nejm.org, or www.jwatch.org


Share on Facebook
Facebook logoLinkedInYouTube logoInstagramThreads

Copyright © 2025. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org